Skip to content
by Legal Desire
2 October 2026

Latham & Watkins Advises Shareholders on Sale of SK Pharma to Arcus Infrastructure Partners

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Burc Hesse Lead Latham & Watkins LLP Partner corporate Munich
Chris Freitag Latham & Watkins LLP Associate Not stated Not stated
Sara Collorio Latham & Watkins LLP Associate Not stated Not stated
Giulia Zöller Latham & Watkins LLP Associate Not stated Not stated
Daniel Hiemer Latham & Watkins LLP Counsel tax Munich
Christian Jahn Latham & Watkins LLP Partner finance Munich
Valentin Mezger Latham & Watkins LLP Associate finance Not stated
Thomas Stüber Latham & Watkins LLP Associate finance Not stated
Max Hauser Latham & Watkins LLP Partner antitrust Frankfurt
David Marder Latham & Watkins LLP Associate antitrust Not stated
Kamilla Zembala Latham & Watkins LLP Associate antitrust Not stated
Deniz Tschammler Latham & Watkins LLP Partner regulatory Frankfurt
Axel Schiemann Latham & Watkins LLP Partner regulatory Frankfurt
Joachim Grittmann Latham & Watkins LLP Partner regulatory Frankfurt

11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Syz Capital, Saturnus Capital, and the founderSell-side
Counterparties
Arcus European Infrastructure Fund 4 (AEIF4) (Buy-side)
reinvesting management team (Investor)